WeVote

Bill

Bill

HB 117

relative to the substitution of biological products.

2025 Regular Session Introduced by Sue Prentiss and 1 co-sponsor

HB 117 regulates automatic substitution of biologic medications in New Hampshire, requiring notification and likely limiting interchangeable product switches to protect treatment continuity.

Signed by Governor Ayotte 07/15/2025; Chapter 163; eff. 09/13/2025 HJ 18
0

WeVote — Public opinion

No community votes yet. Be the first to weigh in from the Vote tab.

Bill text & amendments